1 |
Yin X, Yin X, Pan X, Zhang J, Fan X, Li J, Zhai X, Jiang L, Hao P, Wang J, Chen Y. Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention. Front Pharmacol 2023;14. [DOI: 10.3389/fphar.2023.1070973] [Reference Citation Analysis]
|
2 |
Caño-carrillo S, Lozano-velasco E, Castillo-casas JM, Sánchez-fernández C, Franco D. The Role of ncRNAs in Cardiac Infarction and Regeneration. JCDD 2023;10:123. [DOI: 10.3390/jcdd10030123] [Reference Citation Analysis]
|
3 |
Wang Y, Chen D, Xie H, Zhou S, Jia M, He X, Guo F, Lai Y, Tang XX. LncRNA GAS5 suppresses TGF-β1-induced transformation of pulmonary pericytes into myofibroblasts by recruiting KDM5B and promoting H3K4me2/3 demethylation of the PDGFRα/β promoter. Mol Med 2023;29:32. [PMID: 36918759 DOI: 10.1186/s10020-023-00620-x] [Reference Citation Analysis]
|
4 |
Yan Y, Tian LY, Jia Q, Han Y, Tian Y, Chen HN, Cui SJ, Xi J, Yao YM, Zhao XJ. MiR-130a-3p regulates FUNDC1-mediated mitophagy by targeting GJA1 in myocardial ischemia/reperfusion injury. Cell Death Discov 2023;9:77. [PMID: 36841811 DOI: 10.1038/s41420-023-01372-7] [Reference Citation Analysis]
|
5 |
Li C, Meng X, Wang L, Dai X. Mechanism of action of non-coding RNAs and traditional Chinese medicine in myocardial fibrosis: Focus on the TGF-β/Smad signaling pathway. Front Pharmacol 2023;14:1092148. [PMID: 36843918 DOI: 10.3389/fphar.2023.1092148] [Reference Citation Analysis]
|
6 |
Zhang H, Zhou Y, Wen D, Wang J. Noncoding RNAs: Master Regulator of Fibroblast to Myofibroblast Transition in Fibrosis. Int J Mol Sci 2023;24. [PMID: 36675315 DOI: 10.3390/ijms24021801] [Reference Citation Analysis]
|
7 |
Gwanyanya A, Mubagwa K. Emerging role of transient receptor potential (TRP) ion channels in cardiac fibroblast pathophysiology. Front Physiol 2022;13:968393. [DOI: 10.3389/fphys.2022.968393] [Reference Citation Analysis]
|